Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
Actonel, AIG, alike, appendix, ASP, attached, Biden, Bisaro, blockbuster, Boniva, Borkowski, buyer, Cantor, chaired, choice, CMPL, coagulation, combat, complaint, conserve, counterclaim, covenant, CPRA, cutting, deferral, depression, discretionary, displaced, disregard, distancing, disturbance, divestiture, divesture, EBITDA, Edward, entertainment, equitable, ESPP, EU, Evista, explicitly, Facebook, FDRR, feasibility, fifteen, Fitzgerald, Forteo, Gail, home, immunity, intentionally, Interbank, intervene, Ireland, Jersey, Karen, landscape, legislature, Ling, lipid, London, MFN, micronized, Musing, Naughton, occupy, OfferingSM, onboarded, onboarding, override, overturned, pandemic, Paul, pause, paused, Pennsylvania, Peter, pharmacological, Poor, preapproval, prevail, privilege, purport, quarantine, ramping, reassessed, reassessment, recession, reconciled, refill, refocused, registry, relaunched, rescinded, rescission, Resolution, restarted, resume, resumed, reverted, round, Sandoz, sentence, Sentinel, shifted, shortage, signaling, slower, sooner, sophisticated, spread, styled, subsided, Sun, talent, temporarily, text, uncovered, undo, undrawn, unemployment, upholding, vaccine, vagina, Vice, vouching, withdrew, workforce, Workplace, worse
Removed:
Allergan, amag, Brian, buy, called, capacity, capitalization, Cartwright, century, Daniel, deteriorate, easier, elderly, enact, exempting, expressed, financed, geographic, idling, improvement, Intrarosa, Jr, LaPenta, Mine, MMA, PA, provisional, Quatrefolic, reached, referring, repealed, Stark, submitting, Supplementary, Treasurer, unqualified, vendor
Filing tables
Filing exhibits
- 10-K Annual report
- 10.12 Second Amendment to Company Warrant
- 10.13 Warrant Issued to Robert G. Finizio
- 10.14 Amendment to Warrant Issued to Robert G. Finizio
- 10.15 Warrant Issued to John C.K. Milligan, IV
- 10.16 Amendment to Warrant Issued to John C.K. Milligan, IV
- 10.24 Amendment No. 7 to the Financing Agreement
- 10.25 Amendment No. 8 to the Financing Agreement
- 10.41 Employment Agreement with Edward J. Borkowski
- 10.42 Amendment to Employment Agreement with Edward J. Borkowski
- 23.1 Consent of Grant Thornton LLP
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Certification of Chief Financial Officer
- Download Excel data file
- View Excel data file
Related press release
Associated TXMD transcripts
TXMD similar filings
Filing view
External links
Exhibit 32.2
SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER
In connection with the annual report of TherapeuticsMD, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James C. D’Arecca, Chief Financial Officer of the Company, certify, to my best knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (3) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and |
| (4) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
March 3, 2021
| /s/ James C. D’Arecca | |
| James C. D’Arecca | |
| Chief Financial Officer | |
| (Principal Financial Officer) |
A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
86